ASTM E2327-10 - 15.12.2010
 
Significance and Use

These are minimum standards of quality assurance applicable to laboratories where analysis of seized-drug submissions is performed.

This practice is to be used by forensic analysts performing seized-drug analysis and promoted/supported by laboratory management.

 
1. Scope

1.1 This practice covers quality assurance issues in forensic laboratories performing seized-drug analysis including evidence handling, analytical procedures, report writing, method validation, documentation, proficiency testing, audits, and health and safety.

1.2 This practice is meant to apply only to qualitative seized-drug analysis.

 
2. Referenced Documents

E2549-14

Standard Practice for Validation of Seized-Drug Analytical Methods (Withdrawn 2023)

E1732-25e1

Standard Terminology Relating to Forensic Science (Includes all amendments and changes 10/27/2025).

E1492-25

Standard Practice for Receiving, Documenting, Storing, and Retrieving Evidence by a Forensic Service Provider

E2548-26

Standard Practice for Sampling Seized Drugs for Qualitative and Quantitative Analysis

E620-18

Standard Practice for Reporting Opinions of Scientific or Technical Experts

E2329-25

Standard Practice for Designing Analytical Schemes for the Identification of Chemical Substances in Suspected Seized Drug Evidence

E2326-14

Standard Practice for Education and Training of Seized-Drug Analysts (Withdrawn 2023)

E1459-24

Standard Practice for Physical Evidence Labeling and Related Documentation

E2764-11

Standard Practice for Uncertainty Assessment in the Context of Seized-Drug Analysis (Withdrawn 2020)